PARIS, October 28, 2016 /PRNewswire/ --
Sanofi, a global and diversified healthcare leader, reports results for the third quarter of 2016. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on the results.
Watch video interview and read transcript:
Topics covered in the interview include:
- Q3 highlights
- Cost savings
- Capital allocation
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).